{"id":781987,"date":"2023-09-06T08:56:57","date_gmt":"2023-09-06T12:56:57","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/acelyrin-inc-to-present-at-the-morgan-stanley-21st-annual-global-healthcare-conference\/"},"modified":"2023-09-06T08:56:57","modified_gmt":"2023-09-06T12:56:57","slug":"acelyrin-inc-to-present-at-the-morgan-stanley-21st-annual-global-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/acelyrin-inc-to-present-at-the-morgan-stanley-21st-annual-global-healthcare-conference\/","title":{"rendered":"ACELYRIN, INC. to Present at the Morgan Stanley 21st Annual Global Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">LOS ANGELES, Sept.  06, 2023  (GLOBE NEWSWIRE) &#8212; ACELYRIN, INC. (Nasdaq: SLRN), a late-stage biopharma company focused on accelerating the development and delivery of transformative medicines in immunology, today announced that Founder and Chief Executive Officer Shao-Lee Lin, MD, PhD will participate in a moderated fireside chat during the Morgan Stanley 21<sup>st<\/sup> Annual Global Healthcare Conference being held September 11-13, 2023 in New York.<\/p>\n<p align=\"left\">\n        <strong>Event: Morgan Stanley 21<\/strong><br \/>\n        <sup><br \/>\n          <strong>st<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Global Healthcare Conference<\/strong><br \/>\n        <br \/>Date: Wednesday, September 13<sup>th<\/sup><br \/>Time: 11:30 am ET<\/p>\n<p>A live webcast of Dr. Lin\u2019s fireside chat will be available via the \u201cEvents\u201d section of the Company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6fY4UuWc5vY6crCxa6JEy2Lwm1UN9JJxeaZ2ff1t8sdcQt0bTeba8MXY4m8u7gcfKmyqY-RpzWtYKG84k26DjA==\" rel=\"nofollow noopener\" target=\"_blank\">www.acelyrin.com<\/a>. A replay of the webcast will be archived on the website for 30 days.<\/p>\n<p>\n        <strong>About ACELYRIN<\/strong><br \/>\n        <br \/>ACELYRIN, INC. (Nasdaq: SLRN) is a Los Angeles area-based late-stage clinical biopharma company \u2013 with additional operations in the San Francisco Bay area \u2013 focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating the development and commercialization of transformative medicines.<\/p>\n<p>\n        <strong>Forward Looking Statements<\/strong><br \/>\n        <br \/>Some statements in this press release are, or may be considered, forward-looking statements, including statements regarding ACELYRIN\u2019s business plans, including our plans to initiate additional clinical trials, as well as the potential future benefits of our product candidates. While ACELYRIN, INC. considers any projections to be based on reasonable assumptions, these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those anticipated in such forward-looking statements.<\/p>\n<p>\n        <strong><br \/>\n          <u>CONTACTS<\/u><br \/>\n        <\/strong><br \/>\n        <strong>:<\/strong>\n      <\/p>\n<p>\n        <strong>ACELYRIN, INC.<\/strong><br \/>\n        <br \/>Tyler Marciniak<br \/>Vice President of Investor Relations,<br \/>Communications and Corporate Operations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=L7VojKqk2XN8joJm7NFtujM09VWmTCQ9LEmKgxttqZrTG6KsAoYAG1_sBjVcUxZxMw-roQCqxEA0H1s3CA_mmL9Bkm01cPgs8Tab0MZoL3nJtC8U8fVQOczBqiHNfStCG4xgCANE_uE0BImnyMU6Lss22wuscyqUdJprfc3Sphh-JOwFeybRHgzbsLxNxWugNwLXxsJwJpFi8smF2rMCofCNf4GjOmRe5FkvoW5RLwSNosA3XujyXKkivYexs6NESqhE5wIBCf6K4P3KW76YYw==\" rel=\"nofollow noopener\" target=\"_blank\">investors@acelyrin.com<\/a><br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ohDRUch3ys5LdfRBLv370xRTP5PCdsYZRFyiAdd_84Kdu48BEcaLQUPKuif3gc-dqwZZZZ9BkvO_iK1eqox_Foy6N5jiFSfMJJEo-Sc0zuOYbsdRf6kXOOGaXkXlokvDFv0_6LHjEKkGBp1utLTTZY7FSssm7bz2ZEW-uxhiU-zz16Yv3XIDes97x7Nbybke7apmAb5WHBdVpPKZ_CkDgKkiNq-2ZBWLVYtBfykjmRkMv2n7Y3PGguqiM1h1EtIYRy4kt3cHo-p6sM5YxSpFdQ==\" rel=\"nofollow noopener\" target=\"_blank\">media@acelyrin.com<\/a><\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNzAzNiM1Nzk5NzQ5IzIyNTg4Nzk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/YmQ1MjRmNmYtNTNjNS00YjQ3LTkyMWQtMmM1ZDI4MDE2YWYyLTEyNzA0Mjk=\/tiny\/Acelyrin-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>LOS ANGELES, Sept. 06, 2023 (GLOBE NEWSWIRE) &#8212; ACELYRIN, INC. (Nasdaq: SLRN), a late-stage biopharma company focused on accelerating the development and delivery of transformative medicines in immunology, today announced that Founder and Chief Executive Officer Shao-Lee Lin, MD, PhD will participate in a moderated fireside chat during the Morgan Stanley 21st Annual Global Healthcare Conference being held September 11-13, 2023 in New York. Event: Morgan Stanley 21 st Annual Global Healthcare Conference Date: Wednesday, September 13thTime: 11:30 am ET A live webcast of Dr. Lin\u2019s fireside chat will be available via the \u201cEvents\u201d section of the Company\u2019s website at www.acelyrin.com. A replay of the webcast will be archived on the website for 30 days. About ACELYRIN ACELYRIN, INC. (Nasdaq: &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/acelyrin-inc-to-present-at-the-morgan-stanley-21st-annual-global-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ACELYRIN, INC. to Present at the Morgan Stanley 21st Annual Global Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-781987","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ACELYRIN, INC. to Present at the Morgan Stanley 21st Annual Global Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/acelyrin-inc-to-present-at-the-morgan-stanley-21st-annual-global-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ACELYRIN, INC. to Present at the Morgan Stanley 21st Annual Global Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"LOS ANGELES, Sept. 06, 2023 (GLOBE NEWSWIRE) &#8212; ACELYRIN, INC. (Nasdaq: SLRN), a late-stage biopharma company focused on accelerating the development and delivery of transformative medicines in immunology, today announced that Founder and Chief Executive Officer Shao-Lee Lin, MD, PhD will participate in a moderated fireside chat during the Morgan Stanley 21st Annual Global Healthcare Conference being held September 11-13, 2023 in New York. Event: Morgan Stanley 21 st Annual Global Healthcare Conference Date: Wednesday, September 13thTime: 11:30 am ET A live webcast of Dr. Lin\u2019s fireside chat will be available via the \u201cEvents\u201d section of the Company\u2019s website at www.acelyrin.com. A replay of the webcast will be archived on the website for 30 days. About ACELYRIN ACELYRIN, INC. (Nasdaq: &hellip; Continue reading &quot;ACELYRIN, INC. to Present at the Morgan Stanley 21st Annual Global Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/acelyrin-inc-to-present-at-the-morgan-stanley-21st-annual-global-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-06T12:56:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNzAzNiM1Nzk5NzQ5IzIyNTg4Nzk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acelyrin-inc-to-present-at-the-morgan-stanley-21st-annual-global-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acelyrin-inc-to-present-at-the-morgan-stanley-21st-annual-global-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ACELYRIN, INC. to Present at the Morgan Stanley 21st Annual Global Healthcare Conference\",\"datePublished\":\"2023-09-06T12:56:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acelyrin-inc-to-present-at-the-morgan-stanley-21st-annual-global-healthcare-conference\\\/\"},\"wordCount\":268,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acelyrin-inc-to-present-at-the-morgan-stanley-21st-annual-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxNzAzNiM1Nzk5NzQ5IzIyNTg4Nzk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acelyrin-inc-to-present-at-the-morgan-stanley-21st-annual-global-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acelyrin-inc-to-present-at-the-morgan-stanley-21st-annual-global-healthcare-conference\\\/\",\"name\":\"ACELYRIN, INC. to Present at the Morgan Stanley 21st Annual Global Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acelyrin-inc-to-present-at-the-morgan-stanley-21st-annual-global-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acelyrin-inc-to-present-at-the-morgan-stanley-21st-annual-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxNzAzNiM1Nzk5NzQ5IzIyNTg4Nzk=\",\"datePublished\":\"2023-09-06T12:56:57+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acelyrin-inc-to-present-at-the-morgan-stanley-21st-annual-global-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acelyrin-inc-to-present-at-the-morgan-stanley-21st-annual-global-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acelyrin-inc-to-present-at-the-morgan-stanley-21st-annual-global-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxNzAzNiM1Nzk5NzQ5IzIyNTg4Nzk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxNzAzNiM1Nzk5NzQ5IzIyNTg4Nzk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acelyrin-inc-to-present-at-the-morgan-stanley-21st-annual-global-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ACELYRIN, INC. to Present at the Morgan Stanley 21st Annual Global Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ACELYRIN, INC. to Present at the Morgan Stanley 21st Annual Global Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/acelyrin-inc-to-present-at-the-morgan-stanley-21st-annual-global-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"ACELYRIN, INC. to Present at the Morgan Stanley 21st Annual Global Healthcare Conference - Market Newsdesk","og_description":"LOS ANGELES, Sept. 06, 2023 (GLOBE NEWSWIRE) &#8212; ACELYRIN, INC. (Nasdaq: SLRN), a late-stage biopharma company focused on accelerating the development and delivery of transformative medicines in immunology, today announced that Founder and Chief Executive Officer Shao-Lee Lin, MD, PhD will participate in a moderated fireside chat during the Morgan Stanley 21st Annual Global Healthcare Conference being held September 11-13, 2023 in New York. Event: Morgan Stanley 21 st Annual Global Healthcare Conference Date: Wednesday, September 13thTime: 11:30 am ET A live webcast of Dr. Lin\u2019s fireside chat will be available via the \u201cEvents\u201d section of the Company\u2019s website at www.acelyrin.com. A replay of the webcast will be archived on the website for 30 days. About ACELYRIN ACELYRIN, INC. (Nasdaq: &hellip; Continue reading \"ACELYRIN, INC. to Present at the Morgan Stanley 21st Annual Global Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/acelyrin-inc-to-present-at-the-morgan-stanley-21st-annual-global-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2023-09-06T12:56:57+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNzAzNiM1Nzk5NzQ5IzIyNTg4Nzk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acelyrin-inc-to-present-at-the-morgan-stanley-21st-annual-global-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acelyrin-inc-to-present-at-the-morgan-stanley-21st-annual-global-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ACELYRIN, INC. to Present at the Morgan Stanley 21st Annual Global Healthcare Conference","datePublished":"2023-09-06T12:56:57+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acelyrin-inc-to-present-at-the-morgan-stanley-21st-annual-global-healthcare-conference\/"},"wordCount":268,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acelyrin-inc-to-present-at-the-morgan-stanley-21st-annual-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNzAzNiM1Nzk5NzQ5IzIyNTg4Nzk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acelyrin-inc-to-present-at-the-morgan-stanley-21st-annual-global-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/acelyrin-inc-to-present-at-the-morgan-stanley-21st-annual-global-healthcare-conference\/","name":"ACELYRIN, INC. to Present at the Morgan Stanley 21st Annual Global Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acelyrin-inc-to-present-at-the-morgan-stanley-21st-annual-global-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acelyrin-inc-to-present-at-the-morgan-stanley-21st-annual-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNzAzNiM1Nzk5NzQ5IzIyNTg4Nzk=","datePublished":"2023-09-06T12:56:57+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acelyrin-inc-to-present-at-the-morgan-stanley-21st-annual-global-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/acelyrin-inc-to-present-at-the-morgan-stanley-21st-annual-global-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acelyrin-inc-to-present-at-the-morgan-stanley-21st-annual-global-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNzAzNiM1Nzk5NzQ5IzIyNTg4Nzk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNzAzNiM1Nzk5NzQ5IzIyNTg4Nzk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acelyrin-inc-to-present-at-the-morgan-stanley-21st-annual-global-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ACELYRIN, INC. to Present at the Morgan Stanley 21st Annual Global Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/781987","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=781987"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/781987\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=781987"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=781987"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=781987"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}